Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.26 - $0.64 $166,606 - $410,109
-640,796 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$0.52 - $1.0 $200,018 - $384,650
384,650 Added 150.17%
640,796 $384,000
Q4 2021

Feb 14, 2022

SELL
$0.85 - $1.33 $359,062 - $561,826
-422,426 Reduced 62.25%
256,146 $251,000
Q3 2021

Nov 15, 2021

SELL
$1.03 - $1.41 $13,301 - $18,208
-12,914 Reduced 1.87%
678,572 $882,000
Q2 2021

Aug 16, 2021

BUY
$1.04 - $1.5 $719,145 - $1.04 Million
691,486 New
691,486 $761,000

Others Institutions Holding NMTR

About 9 METERS BIOPHARMA, INC.


  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.